74 related articles for article (PubMed ID: 1823766)
1. [The influence of lipoprotein (a) in thrombolysis with r-TPA for myocardial infarction].
Santos Filho RD; Tranchesi Júnior B; Caramelli B; Barbosa V; Gebara O; de Albuquerque CP; Vinagre C; Maranhão R; Pileggi F
Arq Bras Cardiol; 1991 Jul; 57(1):9-12. PubMed ID: 1823766
[TBL] [Abstract][Full Text] [Related]
2. Effects of lipoprotein (a) on success rate of thrombolytic therapy in acute myocardial infarction.
von Hodenberg E; Kreuzer J; Hautmann M; Nordt T; Kübler W; Bode C
Am J Cardiol; 1991 Jun; 67(16):1349-53. PubMed ID: 1828324
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy.
Qiu SQ; Théroux P; Genest J; Solymoss BC; Robitaille D; Marcil M
Am J Cardiol; 1991 Jun; 67(15):1175-9. PubMed ID: 1827942
[TBL] [Abstract][Full Text] [Related]
4. [Intra-coronary thrombolysis for acute myocardial infarction].
Kimata S
Rinsho Byori; 1990 Jul; Suppl 86():11-24. PubMed ID: 2122047
[No Abstract] [Full Text] [Related]
5. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
[TBL] [Abstract][Full Text] [Related]
6. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
7. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
8. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
van Griensven JM; Koster RW; Burggraaf J; Huisman LG; Kluft C; Kroon R; Schoemaker RC; Cohen AF
Clin Pharmacol Ther; 1998 Jan; 63(1):39-47. PubMed ID: 9465840
[TBL] [Abstract][Full Text] [Related]
9. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) and apolipoproteins B and A-I after acute myocardial infarction.
Husain M; Armstrong PW; Connelly PW; Hegele RA
Can J Cardiol; 1995 Mar; 11(3):206-10. PubMed ID: 7889438
[TBL] [Abstract][Full Text] [Related]
11. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
Johnson TJ
S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948
[No Abstract] [Full Text] [Related]
12. [New substances and dosages for thrombolysis in acute myocardial infarct].
Zeymer U; Neuhaus KL
Z Kardiol; 1993; 82 Suppl 2():137-41. PubMed ID: 8328192
[TBL] [Abstract][Full Text] [Related]
13. Effects of lipoprotein(a) on thrombolysis.
von Hodenberg E; Pestel E; Kreuzer J; Freitag M; Bode C
Chem Phys Lipids; 1994 Jan; 67-68():381-5. PubMed ID: 8187238
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
Chen B; Wang W; Zhao H; Hu D; Xu C; Zhao M; Lu M; Liu J; Wu C
Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
[TBL] [Abstract][Full Text] [Related]
15. [Mutant t-PA compared with native t-PA in acute myocardial infarction].
Nagao K; Kanmatsuse K
Nihon Rinsho; 2003 Apr; 61 Suppl 4():453-6. PubMed ID: 12735014
[No Abstract] [Full Text] [Related]
16. Lack of association between raised serum lipoprotein(a) and thrombolysis.
Tranchesi B; Maranhao R; Cobbaert C; Vanhove P; Verstraete M
Lancet; 1990 Dec 22-29; 336(8730):1587-8. PubMed ID: 1979405
[No Abstract] [Full Text] [Related]
17. Lipoprotein (a) levels do not influence the outcome of rt-PA therapy in acute myocardial infarction.
Tranchesi B; Santos Filho R; Vinagre C; Caramelli B; Barbosa V; Gebara O; Belloti G; Pileggi F; Maranhão R
Ann Hematol; 1991 Apr; 62(4):141-2. PubMed ID: 1827740
[No Abstract] [Full Text] [Related]
18. [Thrombolytic therapy of myocardial infarction (discussion)].
Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1236-48. PubMed ID: 1431465
[No Abstract] [Full Text] [Related]
19. Lack of association between raised serum Lp(a) concentration and unsuccessful thrombolysis after acute myocardial infarction.
Armstrong VW; Neubauer C; Schütz E; Tebbe U
Lancet; 1990 Oct; 336(8722):1077. PubMed ID: 1977059
[No Abstract] [Full Text] [Related]
20. Promotion of thrombin activity by thrombolytic therapy without simultaneous anticoagulation.
Rapold HJ
Lancet; 1990 Feb; 335(8687):481-2. PubMed ID: 1968207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
